These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17268016)
1. Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. Madar I; Bencherif B; Lever J; Heitmiller RF; Yang SC; Brock M; Brahmer J; Ravert H; Dannals R; Frost JJ J Nucl Med; 2007 Feb; 48(2):207-13. PubMed ID: 17268016 [TBL] [Abstract][Full Text] [Related]
2. PET imaging of human cardiac opioid receptors. Villemagne PS; Dannals RF; Ravert HT; Frost JJ Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1385-8. PubMed ID: 12271423 [TBL] [Abstract][Full Text] [Related]
3. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Madar I; Lesser RP; Krauss G; Zubieta JK; Lever JR; Kinter CM; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ Ann Neurol; 1997 Mar; 41(3):358-67. PubMed ID: 9066357 [TBL] [Abstract][Full Text] [Related]
4. Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET. Madar I; Lever JR; Kinter CM; Scheffel U; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ Synapse; 1996 Sep; 24(1):19-28. PubMed ID: 9046073 [TBL] [Abstract][Full Text] [Related]
5. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer. Li G; Low PS Bioorg Med Chem Lett; 2017 May; 27(9):2074-2078. PubMed ID: 28291693 [TBL] [Abstract][Full Text] [Related]
7. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility. Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994 [TBL] [Abstract][Full Text] [Related]
8. Total-body imaging of mu-opioid receptors with [ Hsieh CJ; Hou C; Lee H; Tomita C; Schmitz A; Plakas K; Dubroff JG; Mach RH Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3273-3283. PubMed ID: 38722383 [TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118 [TBL] [Abstract][Full Text] [Related]
10. Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography. Smith JS; Zubieta JK; Price JC; Flesher JE; Madar I; Lever JR; Kinter CM; Dannals RF; Frost JJ J Cereb Blood Flow Metab; 1999 Sep; 19(9):956-66. PubMed ID: 10478647 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. Eschmann SM; Paulsen F; Reimold M; Dittmann H; Welz S; Reischl G; Machulla HJ; Bares R J Nucl Med; 2005 Feb; 46(2):253-60. PubMed ID: 15695784 [TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152 [TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. Hara T; Inagaki K; Kosaka N; Morita T J Nucl Med; 2000 Sep; 41(9):1507-13. PubMed ID: 10994730 [TBL] [Abstract][Full Text] [Related]
14. Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer? Cobben DC; Elsinga PH; Hoekstra HJ; Suurmeijer AJ; Vaalburg W; Maas B; Jager PL; Groen HM J Nucl Med; 2004 Oct; 45(10):1677-82. PubMed ID: 15471832 [TBL] [Abstract][Full Text] [Related]
15. Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects. Wand GS; Weerts EM; Kuwabara H; Frost JJ; Xu X; McCaul ME Psychoneuroendocrinology; 2011 Nov; 36(10):1453-9. PubMed ID: 21549509 [TBL] [Abstract][Full Text] [Related]